Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Breast 4Other hematologic neoplasm 2Thoracic 1Other 1Gynecologic 1Genitourinary 1

Conditions

Obesity 92Overweight 35Neoplasms 32Breast Neoplasms 23Sexual Dysfunction, Physiological 19Dyspnea 15Weight Loss 12Motor Activity 12Endometrial Neoplasms 11Polycystic Ovary Syndrome 10Mucositis 8Diabetes Mellitus, Type 2 8Diabetes Mellitus 8Obesity-Related Malignant Neoplasm 7Hypertension 7Depression 7Anxiety Disorders 7Pediatric Obesity 6Colorectal Neoplasms 6Uterine Cervical Neoplasms 5Sexual Dysfunctions, Psychological 5Obesity, Morbid 5Lung Neoplasms 5Leukemia 5Endometrial Hyperplasia 5Disease 5Constipation 5Sedentary Behavior 4Pulmonary Disease, Chronic Obstructive 4Prostatic Neoplasms 4

Interventions

naldemedine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vomiting × Other × 1 year × Clear all
NCT07038551 2026-06-03

Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study

International University of Health and Welfare

Phase 4 Completed
120 enrolled
Other

Constipation, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡